Indian Breast Cancer Therapeutics Market Expected to Increase at a CAGR 10.7% through 2025
Indian breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 10.7% during the forecast period. The major factors that drive the market include the high prevalence of breast cancer, awareness programs by government and private organizations. Government agencies, NGOs and charity organizations have put great emphasis on improved breast cancer awareness among masses for promotion of early detection, providing comprehensive treatment module, providing support for breast cancer management and rehabilitation. The introduction of project Extension for Community Healthcare Outcomes (ECHO) by organizing breast cancer awareness and screening programs for rural and semi-urban Indian population. This project increased the cancer literacy amongst the rural population and awareness on early diagnosis of breast cancers and more public facilities for breast cancer treatments.
To Request
a Sample of our Report on Indian Breast Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/indian-breast-cancer-therapeutics-market
Indian breast cancer therapeutics
market is segmented on the basis of therapy. The therapy segment is further
classified into chemotherapy, hormone therapy, targeted therapy, radiation
therapy and others (surgery). Among all therapies, chemotherapy market held the
largest market share in the Indian breast cancer therapeutics market.
Chemotherapy is most used when cancer in the lymph nodes and irrespective of
tumor size or menopausal status. Along with that it is used for the treatment
of breast cancer in premenopausal women and referred for those women who diagnosed
with early stage breast cancer for hormone receptor negative and HER2 positive
cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant
chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that
have been spread and not seen by the imaging tests. This method helps in
reducing the cancer cells that form a new tumor in the other place of the body.
Adjuvant chemotherapy reduces the risk of breast cancer coming back.
Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can
be removed with less widespread surgery.
(Get 15% Discount on Buying this Report)
A
full Report of Indian Breast Cancer Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/indian-breast-cancer-therapeutics-market
Indian Breast Cancer Therapeutics Market Segmentation
By Therapy
·
Chemotherapy
·
Hormone Therapy
·
Targeted Therapy
·
Radiation Therapy
·
Others (Surgery)
Company Profiles
·
AbbVie Inc.
·
AstraZeneca PLC
·
Eisai Co., Ltd
·
GlaxoSmithKline PLC
·
Merck & Co., Inc.
·
Novartis International AG
·
F. Hoffmann-La Roche AG
·
Pfizer Inc.
·
Sanofi S.A.
·
Sun Pharmaceutical Industries Ltd.
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment